Full Press Release Details
European Patent Office Grants Patent Related to TECFIDERA® (Dimethyl Fumarate).
BIIB
European Patent Office Grants Patent Related to TECFIDERA® (Dimethyl Fumarate)
Key Takeaway: European Patent Office Grants Patent Related to TECFIDERA® (Dimethyl Fumarate)
Price reaction · baseline $201.74 (2022-06-17 close) · hit after-hours · 1 other BIIB headline(s) in the window, move may be shared
day 0 close · peak
+2.6%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis